Global scientific advances are accelerating, research and clinical studies are expanding, topics of study are increasing, as are publications, journals, and books. E-publishing has participated in this intellectual revolution, and has widened the already expanding scope and reach. Moreover, novel fields increase contemporaneously, e.g. nanotechnology and nanomedicine, imaging and genetics, vaccines for cancer, microorganisms (e.g. bacteria and parasites), and viruses (e.g. HIV, HCV, HBV, and arboviruses), as well as genetic engineering. Genetic engineering in agriculture is ubiquitous; genetic engineering in humans and animals is in progress. All this work requires concomitant development of fields including bioinformatics and modes of analysis. It is among the goals of Bioinformation to continue to promote and be the venue of all these advances and improvements. ( (Figure 1 ) legend, interactions of NF-kB are indicated that involve regulation, co-expression, and actual physical interaction. Molecular processes in this figure include apoptosis, immunology, transcription, chromatin, and regulation of the NF-kB gene itself. Additional interactions are not shown because of the excessive overlapping information that would result in the figure. These include down-regulation, upregulation, predicted protein interaction, and predicted transcription factor interactions. Similarly, only 100 genes are shown since more than that would make the figure illegible.
In summary then, this journal, Bioinformation, has a wide array of bioinformatics in its purview. This Editorial provides a simple scenario of the complexity of molecular information available, already in the literature, even for a single molecule. 
